Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Ready for a Flu Vaccine? What You Should Know About SIRVA and Payment for Vaccine Injury Claims.

Flu season is nearly upon us, which means that millions of Americans will be looking to get a flu shot. The influenza vaccine undoubtedly saves lives. But like any other drug, it can cause some rare, but very serious side … Continue reading

Onglyza Lawsuit Order Permits Direct Filing in Federal Heart Failure Litigation

The federal court overseeing hundreds of heart failure lawsuits involving Onglyza and Kombiglyze XR will allow new plaintiffs to file their cases directly in the multidistrict litigation. Onglyza Lawsuit Direct Filing Will Promote Judicial Efficiency According to an Order issued … Continue reading

Bard IVC Filter Lawsuit in Hands of Jury, as Testimony Concludes in 3rd Federal Bellwether Trial

Testimony has concluded in the nation’s latest trial involving C.R. Bard, Inc.’s allegedly defective retrievable IVC filters. The case is the third bellwether trial convened in the U.S. District Court, District of Arizona, where federally-filed IVC filter lawsuits involving Bard’s … Continue reading

FDA Continues E-Cigarette Crackdown with Surprise Inspection at JUUL Labs

Inspectors from the U.S. Food & Drug Administration (FDA) made a surprise visit to San Francisco-based JUUL Labs last week, as part of the agency’s ongoing crackdown on e-cigarette sales and marketing that targets minors. JUUL Labs sells trendy, USB-shaped … Continue reading

Scientific Journal Finally Acknowledges Monsanto’s Role in Roundup Cancer Studies

A major scientific journal is finally acknowledging the role Monsanto played in a series of studies that refuted a purported link between the company’s Roundup weed killer and certain cancers. According to Bloomberg News, the move will likely bolster Roundup … Continue reading

Investigation Estimates 170,000 in England At Risk for Hernia Mesh Complications

An investigation recently conducted by the BBC is raising new concerns about the risks potentially associated with polypropylene hernia mesh implants, finding that as many as 170,000 patients in England could be struggling with serious complications due to failure of … Continue reading

Hemodialysis Patients on Proton Pump Inhibitors at Increased Risk for Hip Fractures

Proton pump inhibitors, including Nexium, Prilosec, and PrevAcid, may not be the best choice for patients undergoing hemodialysis, especially over the long-term. How Was the Study Conducted? According to research published in the latest edition of the Clinical Journal of the … Continue reading

Stryker Hip Lawsuit Parties at Odds Over Bellwether Trial Pool for Federal LFIT V40 Litigation

The parties to Stryker hip lawsuits involving allegedly defective LFIT V40 femoral head components are at odds over the size of the federal multidistrict litigation’s bellwether trial pool. According to a report from HarrisMartin.com, plaintiffs had recently filed a motion … Continue reading

FDA Bans Imports from Chinese Company at Center of Valsartan Recall

Zhejiang Huahai Pharmaceuticals, the Chinese manufacturer behind recent valsartan recalls, has been banned from importing pharmaceutical ingredients into the United States. The U.S. Food & Drug Administration (FDA) issued an import alert on Friday, September 28th, after an inspection of … Continue reading

Roundup Weed Killer Ingredient May Be Contributing to Honeybee Decline

A new study suggests that glyphosate, the active ingredient in Monsanto’s Roundup weed killer, could be contributing to the decline of the global honeybee population. Glyphosate and Bees: What the Study Found The research, which was published in the journal Proceedings … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content